SPY423.11+2.25 0.53%
DIA339.45+0.67 0.20%
IXIC14,253.27+111.79 0.79%

LogicBio Therapeutics Q1 EPS $(0.32) Up From $(0.41) YoY

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.32) per share. This is a 21.95 percent increase over losses of $(0.41) per share from the same period last year.

05/10/2021 07:33
LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.32) per share. This is a 21.95 percent increase over losses of $(0.41) per share from the same period last year.